পৃষ্ঠা 1 থেকে 24 ফলাফল
TECHNICAL FIELD
The present invention relates generally to compositions and methods for preventing and/or treating inflammation and pain in patients and, more specifically, to compositions containing omega fatty acids and spirulina and to methods for their administration.
BACKGROUND OF THE
This invention relates to the treatment of disorders of inflammation and immunity as well as disorders associated with smooth muscle spasm.
Defects in the biosynthesis and/or metabolism of prostaglandins are now believed to play an important part in disorders of inflammation and immunity, and those
FIELD OF THE INVENTION
This invention relates to compositions for and methods of combating the physical manifestations of ageing, especially inflammatory disorders or defective T-lymphocyte function primarily, but not exclusively, in the field of human medicine.
GENERAL BACKGROUND
Considerable
FIELD OF THE INVENTION
This invention relates to a pet food composition and method for reducing inflammatory response in cats. More particularly, the invention relates to a feline dietary composition that includes omega-3 (n-3) fatty acids, especially the form of the omega-3 fatty acid known as
FIELD OF THE INVENTION
The present disclosure is related to a nutritional composition, in particular a nutritional composition for patients with inflammatory bowel disease. The present disclosure also relates to a method for improving musculoskeletal health in patients, in particular patients with
CROSS REFERENCE TO RELATED APPLICATIONS
The present application is a National Stage of International Application No. PCT/EP2013/065948, filed on Jul. 30, 2013, which claims priority to European Patent Application No. 12178573.7, filed on Jul. 31, 2012, the entire contents of which are being
TECHNICAL FIELD
The present invention relates to a composition for external use on skin that has therapeutic effect on various kinds of inflammatory disease such as dermatitis such as atopic dermatitis, contact dermatitis or UV-caused skin disorder, and rheumatism, psoriasis and lupus.
BACKGROUND
This is the U.S. national stage of application No. PCT/JP2012/062114, filed on 11 May 2012. Priority under 35 U.S.C. .sctn.119(a) and 35 U.S.C. .sctn.365(b) is claimed from Japanese Application No. 2011-107512, filed 12 May 2011, the disclosure of which is also incorporated herein by
FIELD OF THE INVENTION
This invention generally relates to the use of .gamma.-linolenic acid (GLA; 18:3n-6) and stearidonic acid (STA or SDA; 18:4n-3) as substrates for the production of novel oxylipins, and to the oxylipins produced thereby. The invention further relates to the use of SDA, GLA,
FIELD OF THE INVENTION
This invention relates to the treatment of certain diseases and disorders primarily, but not exclusively, in the field of human medicine and to compositions for use therein.
GENERAL BACKGROUND
Considerable interest has been shown in recent years in the use of prostaglandin
FIELD OF THE INVENTION
The present application relates to the field of dietary supplement and to formulations for total enteral or parenteral nutrition and the prevention of fatty acid deficiency.
BACKGROUND OF THE INVENTION
Linoleic acid and alpha-linolenic acid are two fatty acids that cannot be
FIELD OF THE INVENTION
The present application relates to the field of dietary supplement and to formulations for total enteral or parenteral nutrition and the prevention of fatty acid deficiency.
BACKGROUND OF THE INVENTION
Linoleic acid and alpha-linolenic acid are two fatty acids that cannot be
BACKGROUND OF THE INVENTION
Gamma-linolenic acid (GLA) is an essential fatty acid in the omega-6 family that is found primarily in plant-based oils. GLA is synthesized from linoleic acid (LA) via the action of the enzyme delta-six desaturase (.DELTA.6-desaturase). The beneficial effects of GLA
This application is the U.S. national stage entry under 35 U.S.C. .sctn. 371 of international application PCT/US95/16722, filed Dec. 11, 1995.
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is directed to a unique combination of nutritional supplements and a method. More
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is directed to a unique combination of nutritional supplements and a method. More specifically, this invention is directed to a unique combination of nutritional supplements which provides symptomatic relief from arthritis. The